ArticleCell cycle (Georgetown, Tex.)2023

Chk1 inhibition-induced BRCAness synergizes with olaparib in p53-deficient cancer cells.

Yang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.